1. Home
  2. OSUR vs RDIB Comparison

OSUR vs RDIB Comparison

Compare OSUR & RDIB Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo OraSure Technologies Inc.

OSUR

OraSure Technologies Inc.

HOLD

Current Price

$2.91

Market Cap

214.1M

Sector

Health Care

ML Signal

HOLD

RDIB

Reading International Inc Class B

HOLD

Current Price

$10.82

Market Cap

256.7M

ML Signal

HOLD

Company Overview

Basic Information
Metric
OSUR
RDIB
Founded
2000
1937
Country
United States
United States
Employees
N/A
N/A
Industry
Medical/Dental Instruments
Movies/Entertainment
Sector
Health Care
Consumer Discretionary
Exchange
Nasdaq
Nasdaq
Market Cap
214.1M
256.7M
IPO Year
2000
N/A

Fundamental Metrics

Financial Performance
Metric
OSUR
RDIB
Price
$2.91
$10.82
Analyst Decision
Hold
Analyst Count
2
0
Target Price
$3.00
N/A
AVG Volume (30 Days)
484.0K
6.4K
Earning Date
05-06-2026
04-06-2026
Dividend Yield
N/A
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$167,064,000.00
N/A
Revenue This Year
$4.48
N/A
Revenue Next Year
$7.76
$13.42
P/E Ratio
N/A
N/A
Revenue Growth
N/A
N/A
52 Week Low
$2.08
$6.70
52 Week High
$4.22
$17.40

Technical Indicators

Market Signals
Indicator
OSUR
RDIB
Relative Strength Index (RSI) 47.96 41.41
Support Level $2.69 $10.47
Resistance Level $2.99 $12.46
Average True Range (ATR) 0.18 0.49
MACD -0.03 -0.14
Stochastic Oscillator 19.40 21.27

Price Performance

Historical Comparison
OSUR
RDIB

About OSUR OraSure Technologies Inc.

OraSure Technologies Inc is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets majority of its sales from the molecular solutions business, derived mainly from customers in the United States.

About RDIB Reading International Inc Class B

Reading International Inc is a diversified company, engaged in the development, ownership, and operation of multiplex cinemas and retail and commercial real estate in the United States, Australia, and New Zealand. It operates through two segments: the Cinema segment includes Reading Cinemas, Angelika Film Center, Consolidated Theatres, and City Cinemas; the Real Estate segment includes real estate development and the rental or licensing of retail, commercial and live theater assets.

Share on Social Networks: